Gene · 684
Papers3,814
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,814
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects. | Pathogens | 2024 | 38251382 | PubTator, text mining | PubMed |
| Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly. | Nat Commun | 2024 | 38245532 | PubTator, text mining | PubMed |
| In vitro replicative potential of an HIV-1/MO intergroup recombinant virus compared to HIV-1/M and HIV-1/O parental viruses. | Sci Rep | 2024 | 38242913 | PubTator, text mining | PubMed |
| Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review). | Oncol Rep | 2024 | 38240088 | PubTator, text mining | PubMed |
| Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity. | Nat Commun | 2024 | 38238298 | PubTator, text mining | PubMed |
| Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans. | EBioMedicine | 2024 | 38215691 | PubTator, text mining | PubMed |
| BST2 promotes gastric cancer metastasis under the regulation of HOXD9 and PABPC1. | Mol Carcinog | 2024 | 38197534 | PubTator, text mining | PubMed |
| Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin. | PLoS Pathog | 2024 | 38190411 | PubTator, text mining | PubMed |
| TLR-mediated aggresome-like induced structures comprise antimicrobial peptides and attenuate intracellular bacterial survival. | Mol Biol Cell | 2024 | 38170582 | PubTator, text mining | PubMed |
| Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice. | Nat Commun | 2024 | 38169466 | PubTator, text mining | PubMed |
| CD317+ MSCs expanded with chemically defined media have enhanced immunological anti-inflammatory activities. | Stem Cell Res Ther | 2024 | 38169422 | PubTator, text mining | PubMed |
| 2',3' cyclic nucleotide 3' phosphodiesterase 1 functional isoform antagonizes HIV-1 particle assembly. | Life Sci Alliance | 2024 | 38167610 | PubTator, text mining | PubMed |
| The Regulatory Network of CREB3L1 and Its Roles in Physiological and Pathological Conditions. | Int J Med Sci | 2024 | 38164349 | PubTator, text mining | PubMed |
| Exploring biomarkers in trigeminal neuralgia patients operated with microvascular decompression: A comparison with multiple sclerosis patients and non-neurological controls. | Eur J Pain | 2024 | 38158702 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
| Higher BST2 Expression Promotes the Anti-HBV Effect of IFN-α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg-Positive Chronic Hepatitis B Patients. | Clin Pharmacol Ther | 2024 | 38018367 | PubTator, text mining | PubMed |
| Endothelial cells adopt a pro-reparative immune responsive signature during cardiac injury. | Life Sci Alliance | 2024 | 38012001 | PubTator, text mining | PubMed |
| CENPN suppresses autophagy and increases paclitaxel resistance in nasopharyngeal carcinoma cells by inhibiting the CREB-VAMP8 signaling axis. | Autophagy | 2024 | 37776538 | PubTator, text mining | PubMed |
| Sequencing of Physically Interacting Cells in Human Kidney Allograft Rejection to Infer Contact-dependent Immune Cell Transcription. | Transplantation | 2024 | 37638864 | PubTator, text mining | PubMed |
| The autophagy-related protein ATG5 is a central mediator of a non-canonical autophagy pathway hijacked by HIV-1 to weaken the host's response to infection. | Autophagy | 2024 | 37424095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/684/papers?page=10